Contact

All Stories

  1. The heterogeneous roles of neutrophils in gastric cancer: scaffold or target?

    Article • Cellular & Molecular Biology Letters, June 2025, Springer Science + Business Media

    Dr Peixin Dong

  2. N6-methyladenosine RNA modification in stomach carcinoma: Novel insights into mechanisms and implications for diagnosis and treatment

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, June 2025, Elsevier

    Dr Peixin Dong

  3. Editorial Expression of Concern: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer

    Article • Oncogene, January 2025, Springer Science + Business Media

    Dr Peixin Dong

  4. Knockout or inhibition of DHPS suppresses ovarian tumor growth and metastasis by attenuating the TGFβ pathway

    Article • Scientific Reports, January 2025, Springer Science + Business Media

    Dr Peixin Dong

  5. The prognostic analysis and a machine-learning based disease-specific survival state model in pulmonary large-cell neuroendocrine carcinomas

    Article • Journal of Thoracic Disease, August 2024, AME Publishing Company

    Dr Peixin Dong

  6. Causal associations between psoriasis and chronic respiratory disease: a mendelian randomization study

    Article • Archives of Dermatological Research, June 2024, Springer Science + Business Media

    Dr Peixin Dong

  7. Association of systemic inflammation markers in cancer mortality with diabetes: evidence from National Health and Nutrition Examination Survey

    Article • Acta Diabetologica, May 2024, Springer Science + Business Media

    Dr Peixin Dong

  8. Unveiling the Link between Asthma and Cancer Risk: Shedding New Light through Mendelian Randomization

    Article • Archivos de Bronconeumología, March 2024, Elsevier

    Dr Peixin Dong

  9. Editorial: New insights into the role of tumor microbial microenvironment in tumor immunotherapy

    Article • Frontiers in Cellular and Infection Microbiology, February 2024, Frontiers

    Dr Peixin Dong

  10. FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K/AKT/mTOR pathway

    Article • Thoracic Cancer, February 2024, Wiley

    Dr Peixin Dong

  11. Editorial: Transcriptome analysis in tumor microenvironment and tumor heterogeneity

    Article • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, January 2024, Tsinghua University Press

    Dr Peixin Dong

  12. New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets

    Article • Non-coding RNA Research, December 2023, Elsevier

    Dr Peixin Dong

  13. Basal cell carcinoma is causally associate with the increased COVID-19 susceptibility and hospitalization

    Article • Microbial Pathogenesis, December 2023, Elsevier

    Dr Peixin Dong

  14. Comparison of XBB and BA.5.2: Differences in Clinical Characteristics and Disease Outcomes

    Article • Archivos de Bronconeumología, November 2023, Elsevier

    Dr Peixin Dong

  15. Emerging functions and clinical applications of exosomal microRNAs in diseases

    Article • Non-coding RNA Research, September 2023, Elsevier

    Dr Peixin Dong

  16. Uncommon Presentation of COVID-19: XBL Variant

    Article • Archivos de Bronconeumología, September 2023, Elsevier

    Dr Peixin Dong

  17. Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey

    Article • Revista de Oncología, July 2023, Springer Science + Business Media

    Dr Peixin Dong

  18. Editorial: Insights into non-coding RNAs in programmed cell death, from molecular mechanism of tumorigenesis to therapeutic targets

    Article • Frontiers in Oncology, June 2023, Frontiers

    Dr Peixin Dong

  19. Editorial: Non-coding RNA in improving the efficacy of cancer immunotherapy

    Article • Frontiers in Immunology, May 2023, Frontiers

    Dr Peixin Dong

  20. The significance of N6-methyladenosine-modified non-coding RNAs in different disorders

    Article • European Journal of Pharmacology, May 2023, Elsevier

    Dr Peixin Dong

  21. Transcriptome and single‐cell sequencing analysis in tumor microenvironment

    Article • The Journal of Gene Medicine, April 2023, Wiley

    Dr Peixin Dong

  22. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer

    Article • Journal of Translational Medicine, February 2023, Springer Science + Business Media

    Dr Peixin Dong

  23. Editorial: Non-coding RNAs in gastrointestinal and gynecological cancers: New insights into the mechanisms of cancer therapeutic resistance, volume II

    Article • Frontiers in Cell and Developmental Biology, February 2023, Frontiers

    Dr Peixin Dong

  24. A review on the role of cyclin dependent kinases in cancers

    Article • Cancer Cell International, October 2022, Springer Science + Business Media

    Dr Peixin Dong

  25. Cryptotanshinone inhibits ovarian tumor growth and metastasis by degrading c-Myc and attenuating the FAK signaling pathway

    Article • Frontiers in Cell and Developmental Biology, September 2022, Frontiers

    Dr Peixin Dong

  26. Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin

    Article • Journal of Experimental & Clinical Cancer Research, September 2022, Springer Science + Business Media

    Dr Peixin Dong

  27. Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143

    Article • Frontiers in Oncology, May 2022, Frontiers

    Dr Peixin Dong

  28. Editorial: Risks and Benefits of Adjuvants to Cancer Therapies

    Article • Frontiers in Oncology, May 2022, Frontiers

    Dr Peixin Dong

  29. Editorial: Non-Coding RNAs in Gastrointestinal and Gynecological Cancers: New Insights Into the Mechanisms of Cancer Therapeutic Resistance

    Article • Frontiers in Cell and Developmental Biology, May 2022, Frontiers

    Dr Peixin Dong

  30. FAK PROTAC Inhibits Ovarian Tumor Growth and Metastasis by Disrupting Kinase Dependent and Independent Pathways

    Article • Frontiers in Oncology, April 2022, Frontiers

    Dr Peixin Dong

  31. PIWI-Interacting RNAs (piRNAs): Promising Applications as Emerging Biomarkers for Digestive System Cancer

    Article • Frontiers in Molecular Biosciences, January 2022, Frontiers

    Dr Peixin Dong

  32. LncRNAs: Novel Biomarkers for Pancreatic Cancer

    Article • Biomolecules, November 2021, MDPI AG

    Dr Peixin Dong

  33. Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway

    Article • Journal of Experimental & Clinical Cancer Research, June 2021, Springer Science + Business Media

    Dr Peixin Dong

  34. EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway

    Article • Cell & Bioscience, April 2021, Springer Science + Business Media

    Dr Peixin Dong

  35. Critical Roles of PIWIL1 in Human Tumors: Expression, Functions, Mechanisms, and Potential Clinical Implications

    Article • Frontiers in Cell and Developmental Biology, February 2021, Frontiers

    Dr Peixin Dong

  36. A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways

    Article • Journal of Cancer, January 2021, Ivyspring International Publisher

    Dr Peixin Dong

  37. PD-L1 Is a Tumor Suppressor in Aggressive Endometrial Cancer Cells and Its Expression Is Regulated by miR-216a and lncRNA MEG3

    Article • Frontiers in Cell and Developmental Biology, December 2020, Frontiers

    Dr Peixin Dong

  38. Zinc regulates primary ovarian tumor growth and metastasis through the epithelial to mesenchymal transition

    Article • Free Radical Biology and Medicine, November 2020, Elsevier

    Dr Peixin Dong

  39. The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers

    Article • Cancers, June 2020, MDPI AG

    Dr Peixin Dong

  40. MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1

    Article • Cells, March 2020, MDPI AG

    Dr Peixin Dong

  41. L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy

    Article • Annals of Surgical Oncology, December 2019, Springer Science + Business Media

    Dr Peixin Dong

  42. Ovarian primary and metastatic tumors suppressed by survivin knockout or a novel survivin inhibitor

    Article • Molecular Cancer Therapeutics, September 2019, American Association for Cancer Research (AACR)

    Dr Peixin Dong

  43. MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment Formation

    Article • Cancers, August 2019, MDPI AG

    Dr Peixin Dong

  44. Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes

    Article • Journal of Experimental & Clinical Cancer Research, July 2019, Springer Science + Business Media

    Dr Peixin Dong

  45. Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges

    Article • Cancers, February 2019, MDPI AG

    Dr Peixin Dong

  46. Molecular-targeted therapies and precision medicine for endometrial cancer

    Article • Japanese Journal of Clinical Oncology, November 2018, Oxford University Press (OUP)

    Dr Peixin Dong

  47. Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors

    Article • Frontiers in Genetics, October 2018, Frontiers

    Dr Peixin Dong

  48. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway

    Article • Journal of Experimental & Clinical Cancer Research, September 2018, Springer Science + Business Media

    Dr Peixin Dong

  49. Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion

    Article • Frontiers in Oncology, September 2018, Frontiers

    Dr Peixin Dong

  50. B7H3 As a Promoter of Metastasis and Promising Therapeutic Target

    Article • Frontiers in Oncology, July 2018, Frontiers

    Dr Peixin Dong

  51. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women

    Article • Cancer Science, May 2018, Wiley

    Dr Sharon J.B. Hanley, Dr Peixin Dong

  52. Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer

    Article • Oncogene, May 2018, Springer Science + Business Media

    Dr Peixin Dong

  53. miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation

    Article • Oncotarget, April 2018, Impact Journals, LLC

    Dr Peixin Dong

  54. Lentiviral vector mediated-ASAP1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells

    Article • Oncology Letters, January 2018, Spandidos Publications

    Dr Peixin Dong

  55. Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells

    Article • Journal of Cancer, January 2018, Ivyspring International Publisher

    Dr Peixin Dong

  56. Applications of CRSIPR/Cas9 in Cancer Research

    Article • Journal of Cancer Science and Research, January 2018, OMICS Publishing Group

    Dr Peixin Dong

  57. Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells

    Article • Oncotarget, November 2017, Impact Journals, LLC

    Dr Peixin Dong

  58. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation

    Article • Journal of Experimental & Clinical Cancer Research, October 2017, Springer Science + Business Media

    Dr Peixin Dong

  59. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis

    Article • Scientific Reports, July 2017, Nature

    Dr Peixin Dong

  60. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling

    Article • Journal of Experimental & Clinical Cancer Research, April 2017, Springer Science + Business Media

    Dr Peixin Dong

  61. KLF4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells

    Article • Biochemical and Biophysical Research Communications, March 2017, Elsevier

    Dr Peixin Dong

  62. EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis

    Article • Oncotarget, February 2017, Impact Journals, LLC

    Dr Peixin Dong

  63. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells

    Article • Journal of Cancer, January 2017, Ivyspring International Publisher

    Dr Peixin Dong

  64. Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124

    Article • Scientific Reports, October 2016, Nature

    Dr Peixin Dong

  65. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells

    Article • Journal of Experimental & Clinical Cancer Research, September 2016, Springer Science + Business Media

    Dr Peixin Dong

  66. Challenges in breast and cervical cancer control in Japan

    Article • The Lancet Oncology, September 2016, Elsevier

    Dr Peixin Dong

  67. HPV self-sampling in Japanese women: A feasibility study in a population with limited experience of tampon use

    Article • Journal of Medical Screening, July 2016, SAGE Publications

    Dr Sharon J.B. Hanley, Dr Peixin Dong

  68. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression

    Article • Oncotarget, April 2016, Impact Journals, LLC

    Dr Peixin Dong

  69. Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors

    Article • Oncotarget, August 2015, Impact Journals, LLC

    Dr Peixin Dong

  70. Molecular targets and targeted therapy

    Article • November 2014, Future Medicine

    Dr Peixin Dong

  71. Genetic model of endometrial carcinogenesis

    Article • November 2014, Future Medicine

    Dr Peixin Dong

  72. The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer

    Article • Journal of Translational Medicine, August 2014, Springer Science + Business Media

    Dr Peixin Dong

  73. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

    Article • Oncotarget, August 2014, Impact Journals, LLC

    Dr Peixin Dong

  74. Distribution of Lymph Node Metastasis Sites in Endometrial Cancer Undergoing Systematic Pelvic and Para-Aortic Lymphadenectomy: A Proposal of Optimal Lymphadenectomy for Future Clinical Trials

    Article • Annals of Surgical Oncology, April 2014, Springer Science + Business Media

    Dr Peixin Dong

  75. Correction: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway

    Article • Molecular Cancer, January 2014, Springer Science + Business Media

    Dr Peixin Dong

  76. microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway

    Article • Molecular Cancer, January 2014, Springer Science + Business Media

    Dr Peixin Dong

  77. Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer

    Article • Carcinogenesis, November 2013, Oxford University Press (OUP)

    Dr Peixin Dong

  78. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines

    Article • Molecular Carcinogenesis, September 2013, Wiley

    Dr Peixin Dong

  79. Abstract 5293: Prognostic significance of miR-194 in endometrial cancer.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Peixin Dong

  80. Prognostic significance of miR-194 in endometrial cancer

    Article • Biomarker Research, January 2013, Springer Science + Business Media

    Dr Peixin Dong

  81. Emerging Therapeutic Biomarkers in Endometrial Cancer

    Article • BioMed Research International, January 2013, Hindawi Publishing Corporation

    Dr Peixin Dong

  82. Mutant p53 gain-of-function induces EMT through modulation of the miR-130b–ZEB1 axis

    Article • Oncogene, July 2012, Springer Science + Business Media

    Dr Peixin Dong

  83. New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system

    Article • Journal of Surgical Oncology, June 2012, Wiley

    Dr Peixin Dong

  84. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

    Article • Molecular Cancer, January 2011, Springer Science + Business Media

    Dr Peixin Dong

  85. Allopurinol Attenuates Oxidative Stress and Cardiac Fibrosis in Angiotensin II-Induced Cardiac Diastolic Dysfunction

    Article • Cardiovascular Therapeutics, October 2010, Wiley

    Dr Peixin Dong

  86. CARDIOPROTECTIVE EFFECTS OF GRANULOCYTE COLONY-STIMULATING FACTOR IN ANGIOTENSIN II-INDUCED CARDIAC REMODELLING

    Article • Clinical and Experimental Pharmacology and Physiology, March 2009, Wiley

    Dr Peixin Dong

  87. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway

    Article • Molecular Cancer, January 2009, Springer Science + Business Media

    Dr Peixin Dong

  88. Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro

    Article • Journal of Experimental & Clinical Cancer Research, November 2008, Springer Science + Business Media

    Dr Peixin Dong

  89. p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells

    Article • Clinical & Experimental Metastasis, July 2007, Springer Science + Business Media

    Dr Peixin Dong

  90. Overexpression and diffuse expression pattern of IQGAP1 at invasion fronts are independent prognostic parameters in ovarian carcinomas

    Article • Cancer Letters, November 2006, Elsevier

    Dr Peixin Dong